| Richard Lovy, DO | |
|
5007 Meadow Springs Trl Se, Ada, MI 49301-8156 | |
| (616) 719-2293 | |
| Not Available |
| Full Name | Richard Lovy |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 22 Years |
| Location | 5007 Meadow Springs Trl Se, Ada, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407882855 | NPI | - | NPPES |
| 4868850 | Medicaid | MI | |
| RL015392 | Other | MI | BCBS |
| Facility Name | Location | Facility Type |
|---|---|---|
| Borgess Medical Center | Kalamazoo, MI | Hospital |
| Three Rivers Health | Three rivers, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension Medical Group Promed | 7315856077 | 233 |
News Archive
An international delegation from AIDS Healthcare Foundation (AHF), the largest AIDS group in the US which currently provides medical care to more than 98,000 individuals in 21 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, met today with officials from the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) to call for action and partnership to vastly increase global access to HIV/AIDS treatment, testing and condoms.
It isn't a death sentence if a COVID-19 patient suffers a cardiac arrest while getting treatment for the virus in the hospital, according to new research that contradicts reports from early on in the pandemic.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the emerging field of cancer metabolism, announced today that it has received funding from Accelerate Brain Cancer Cure (ABC2), a non-profit organization that supports brain cancer research. ABC2's funding will enable new research investigating IDH1 gene mutations in brain cancer, with the goal of supplementing Agios's ongoing research into the development of new IDH1 therapeutics and diagnostics.
Excelsior Medical Corporation, one of the leading manufacturers of pre-filled catheter flush syringes, today announced that it has received a Medical Device License from Health Canada for its new, pre-filled catheter lock syringe to be sold in the Canadian marketplace.
The critical care doctor Julio Barado-Hualde (Villava, Navarre, 1965) has developed a mathematical simulation model that enables the occupancy of beds in an ICU (Intensive Care Unit) to be predicted so that they can be managed more effectively. This research, which focusses on the Hospital Complex of Navarre, is part of his PhD thesis read at the NUP/UPNA-Public University of Navarre.
› Verified 1 days ago
| Entity Name | Ascension Medical Group Promed |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497709869 PECOS PAC ID: 7315856077 Enrollment ID: O20031216000478 |
News Archive
An international delegation from AIDS Healthcare Foundation (AHF), the largest AIDS group in the US which currently provides medical care to more than 98,000 individuals in 21 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, met today with officials from the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) to call for action and partnership to vastly increase global access to HIV/AIDS treatment, testing and condoms.
It isn't a death sentence if a COVID-19 patient suffers a cardiac arrest while getting treatment for the virus in the hospital, according to new research that contradicts reports from early on in the pandemic.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the emerging field of cancer metabolism, announced today that it has received funding from Accelerate Brain Cancer Cure (ABC2), a non-profit organization that supports brain cancer research. ABC2's funding will enable new research investigating IDH1 gene mutations in brain cancer, with the goal of supplementing Agios's ongoing research into the development of new IDH1 therapeutics and diagnostics.
Excelsior Medical Corporation, one of the leading manufacturers of pre-filled catheter flush syringes, today announced that it has received a Medical Device License from Health Canada for its new, pre-filled catheter lock syringe to be sold in the Canadian marketplace.
The critical care doctor Julio Barado-Hualde (Villava, Navarre, 1965) has developed a mathematical simulation model that enables the occupancy of beds in an ICU (Intensive Care Unit) to be predicted so that they can be managed more effectively. This research, which focusses on the Hospital Complex of Navarre, is part of his PhD thesis read at the NUP/UPNA-Public University of Navarre.
› Verified 1 days ago
| Entity Name | Metropolitan Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811937519 PECOS PAC ID: 5597651836 Enrollment ID: O20040507000012 |
News Archive
An international delegation from AIDS Healthcare Foundation (AHF), the largest AIDS group in the US which currently provides medical care to more than 98,000 individuals in 21 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, met today with officials from the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) to call for action and partnership to vastly increase global access to HIV/AIDS treatment, testing and condoms.
It isn't a death sentence if a COVID-19 patient suffers a cardiac arrest while getting treatment for the virus in the hospital, according to new research that contradicts reports from early on in the pandemic.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the emerging field of cancer metabolism, announced today that it has received funding from Accelerate Brain Cancer Cure (ABC2), a non-profit organization that supports brain cancer research. ABC2's funding will enable new research investigating IDH1 gene mutations in brain cancer, with the goal of supplementing Agios's ongoing research into the development of new IDH1 therapeutics and diagnostics.
Excelsior Medical Corporation, one of the leading manufacturers of pre-filled catheter flush syringes, today announced that it has received a Medical Device License from Health Canada for its new, pre-filled catheter lock syringe to be sold in the Canadian marketplace.
The critical care doctor Julio Barado-Hualde (Villava, Navarre, 1965) has developed a mathematical simulation model that enables the occupancy of beds in an ICU (Intensive Care Unit) to be predicted so that they can be managed more effectively. This research, which focusses on the Hospital Complex of Navarre, is part of his PhD thesis read at the NUP/UPNA-Public University of Navarre.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Lovy, DO 5007 Meadow Springs Trl Se, Ada, MI 49301-8156 Ph: (616) 719-2293 | Richard Lovy, DO 5007 Meadow Springs Trl Se, Ada, MI 49301-8156 Ph: (616) 719-2293 |
News Archive
An international delegation from AIDS Healthcare Foundation (AHF), the largest AIDS group in the US which currently provides medical care to more than 98,000 individuals in 21 countries worldwide in the US, Africa, Latin America/Caribbean and Asia, met today with officials from the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) to call for action and partnership to vastly increase global access to HIV/AIDS treatment, testing and condoms.
It isn't a death sentence if a COVID-19 patient suffers a cardiac arrest while getting treatment for the virus in the hospital, according to new research that contradicts reports from early on in the pandemic.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the emerging field of cancer metabolism, announced today that it has received funding from Accelerate Brain Cancer Cure (ABC2), a non-profit organization that supports brain cancer research. ABC2's funding will enable new research investigating IDH1 gene mutations in brain cancer, with the goal of supplementing Agios's ongoing research into the development of new IDH1 therapeutics and diagnostics.
Excelsior Medical Corporation, one of the leading manufacturers of pre-filled catheter flush syringes, today announced that it has received a Medical Device License from Health Canada for its new, pre-filled catheter lock syringe to be sold in the Canadian marketplace.
The critical care doctor Julio Barado-Hualde (Villava, Navarre, 1965) has developed a mathematical simulation model that enables the occupancy of beds in an ICU (Intensive Care Unit) to be predicted so that they can be managed more effectively. This research, which focusses on the Hospital Complex of Navarre, is part of his PhD thesis read at the NUP/UPNA-Public University of Navarre.
› Verified 1 days ago
Dr. Ashley Barcroft, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 7128 Fulton St E, Ada, MI 49301 Phone: 616-825-3530 | |
Andrew Lewandoski, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6741 Fulton St E, Ada, MI 49301 Phone: 616-320-5330 Fax: 616-320-5331 | |
Dr. Peter C Lenhart, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6741 E Fulton St, Ste 201, Ada, MI 49301 Phone: 616-685-2500 Fax: 616-685-2511 | |
Dr. James Douglas Birmingham, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6741 Fulton St E, Ada, MI 49301 Phone: 616-320-5330 Fax: 616-320-5331 |